Dabrafenib Mesylate and Tetracycline (class) Oral, Parenteral
Determining the interaction of Dabrafenib Mesylate and Tetracycline (class) Oral, Parenteral and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dabrafenib
Brand name: Tafinlar
Synonyms: Dabrafenib
Generic Name: tetracycline
Brand name: Ala-Tet, Brodspec, Panmycin, Sumycin, Tetracap, Tetracon, Robitet 500, Emtet-500
Synonyms: Tetracycline, Tetracycline (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dabrafenib Mesylate-Tetracycline (Systemic)
- Dabrafenib Mesylate-Tetracycline Hydrochloride
- Dabrafenib Mesylate-Tetracycline Mucous membrane, oral
- Dabrafenib Mesylate-Tetracycline Topical application
- Dabrafenib Mesylate-Tetrahydrozoline (Nasal)
- Dabrafenib Mesylate-Tetrahydrozoline and zinc ophthalmic
- Tetracycline (class) Oral, Parenteral-Dacarbazine
- Tetracycline (class) Oral, Parenteral-Dacarbazine Intravenous, Injection
- Tetracycline (class) Oral, Parenteral-Daclatasvir
- Tetracycline (class) Oral, Parenteral-Daclatasvir Dihydrochloride
- Tetracycline (class) Oral, Parenteral-Daclizumab
- Tetracycline (class) Oral, Parenteral-Daclizumab Subcutaneous